Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer

Lung Cancer

Volumn 49, Issue 3, 2005, Pages 325-335

  Kim, Seok Jin ^a,b   Rabbani, Zahid N ^a   Dewhirst, Mark W ^a   Vujaskovic, Zeljko ^a   Vollmer, Robin T ^a   Schreiber, Ernst Gilbert ^c   Oosterwijk, Egbert ^d   Kelley, Michael J ^a,e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Korea University Ansan Hospital   (South Korea)

^c UNIVERSITY OF UTAH   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e University of Utah ^*  (United States)

Author keywords

Lung cancer; Predictive markers; Tumor hypoxia

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; CA9 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR ANTIGEN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RELIABILITY; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TUMOR NECROSIS; ANOXIA; BIOSYNTHESIS; DISEASE FREE SURVIVAL; LUNG TUMOR; METABOLISM; MIDDLE AGED; NECROSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANOXIA; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23744479831     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.036     Document Type: Article

References (56)

1. M. Hockel, and P. Vaupel Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects J Natl Cancer Inst 93 2001 266 276
2. M. Hockel, B. Vorndran, K. Schlenger, E. Baussmann, and P.G. Knapstein Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix Gynecol Oncol 51 1993 141 149
3. T.G. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, and S.W. Lowe Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91
4. M. Hockel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 1996 4509 4515
5. E.K. Rofstad Microenvironment-induced cancer metastasis Int J Radiat Biol 76 2000 589 605
6. J.M. Brown, and Q.T. Le Tumor hypoxia is important in radiotherapy, but how should we measure it? Int J Radiat Oncol Biol Phys 54 2002 1299 1301
7. J.H. Kaanders, K.I. Wijffels, H.A. Marres, A.S. Ljungkvist, L.A. Pop, and F.J. van den Hoogen Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res 62 2002 7066 7074
8. S.M. Evans, S. Hahn, D.R. Pook, W.T. Jenkins, A.A. Chalian, and P. Zhang Detection of hypoxia in human squamous cell carcinoma by EF5 binding Cancer Res 60 2000 2018 2024
9. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
10. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
11. G.L. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia J Appl Physiol 88 2000 1474 1480
12. 2 tension Am J Physiol 271 1996 C1172 C1180
13. 2-dependent degradation domain via the ubiquitin-proteasome pathway Proc Natl Acad Sci USA 95 1998 7987 7992
14. P.J. Kallio, W.J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway J Biol Chem 274 1999 6519 6525
15. D.M. Aebersold, P. Burri, K.T. Beer, J. Laissue, V. Djonov, and R.H. Greiner Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer Cancer Res 61 2001 2911 2916
16. K.L. Talks, H. Turley, K.C. Gatter, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages Am J Pathol 157 2000 411 421
17. H.K. Haugland, V. Vukovic, M. Pintilie, A.W. Fyles, M. Milosevic, and R.P. Hill Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation Int J Radiat Oncol Biol Phys 53 2002 854 861
18. A. Giatromanolaki, M.I. Koukourakis, E. Sivridis, H. Turley, C.C. Wykoff, and K.C. Gatter DEC1 (STRA13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer J Pathol 200 2003 222 228
19. A. Giatromanolaki, M.I. Koukourakis, E. Sivridis, H. Turley, K. Talks, and F. Pezzella Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival Br J Cancer 85 2001 881 890
20. M. Volm, and R. Koomagi Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer Anticancer Res 20 2000 1527 1533
21. C.C. Wykoff, N.J. Beasley, P.H. Watson, K.J. Turner, J. Pastorek, and A. Sibtain Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res 60 2000 7075 7083
22. C. Blancher, and A.L. Harris The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target Cancer Metastasis Rev 17 1998 187 194
23. R. Opavsky, S. Pastorekova, V. Zelnik, A. Gibadulinova, E.J. Stanbridge, and J. Zavada Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships Genomics 33 1996 480 487
24. S.V. Ivanov, I. Kuzmin, M.H. Wei, S. Pack, L. Geil, and B.E. Johnson Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes Proc Natl Acad Sci USA 95 1998 12596 12601
25. M. Yamagata, K. Hasuda, T. Stamato, and I.F. Tannock The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase Br J Cancer 77 1998 1726 1731
26. J.A. Loncaster, A.L. Harris, S.E. Davidson, J.P. Logue, R.D. Hunter, and C.C. Wycoff Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix Cancer Res 61 2001 6394 6399
27. A. Giatromanolaki, M.I. Koukourakis, E. Sivridis, J. Pastorek, C.C. Wykoff, and K.C. Gatter Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer Cancer Res 61 2001 7992 7998
28. D. Hedley, M. Pintilie, J. Woo, A. Morrison, D. Birle, and A. Fyles Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas Clin Cancer Res 9 2003 5666 5674
29. D.E. Swinson, J.L. Jones, D. Richardson, C. Wykoff, H. Turley, and J. Pastorek Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer J Clin Oncol 21 2003 473 482
30. S.J. Kim, Z.N. Rabbani, R.T. Vollmer, E.G. Schreiber, E. Oosterwijk, and M.W. Dewhirst Carbonic anhydrase IX in early stage non-small cell lung cancer Clin Cancer Res 10 2004 7925 7933
31. A. Jones, C. Fujiyama, C. Blanche, J.W. Moore, S. Fuggle, and D. Cranston Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines Clin Cancer Res 7 2001 1263 1272
32. D.E. Swinson, J.L. Jones, D. Richardson, G. Cox, J.G. Edwards, and K.J. O'Byrne Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables Lung Cancer 37 2002 235 240
33. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
34. W.R. Smythe Treatment of stage I non-small cell lung carcinoma Chest 123 2003 181S 187S
35. H.S. Kim, H.R. Youm, J.S. Lee, K.W. Min, J.H. Chung, and C.S. Park Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer Lung Cancer 42 2003 163 170
36. W. Sienel, J. Hellers, A. Morresi-Hauf, R. Lichtinghagen, W. Mutschler, and M. Jochum Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer Int J Cancer 103 2003 647 651
37. K. Minami, Y. Saito, H. Imamura, and A. Okamura Prognostic significance of p53, Ki-67 VEGF and Glut-1 in resected stage I adenocarcinoma of the lung Lung Cancer 38 2002 51 57
38. D. Masuya, C. Huang, D. Liu, K. Kameyama, E. Hayashi, and A. Yamauchi The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients Cancer 92 2001 2628 2638
39. H.L. Janssen, K.M. Haustermans, D. Sprong, G. Blommestijn, I. Hofland, and F.J. Hoebers HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors Int J Radiat Oncol Biol Phys 54 2002 1537 1549
40. R.H. Thomlinson, and L.H. Gray The histological structure of some human lung cancers and the possible implications for radiotherapy Br J Cancer 9 1955 539 549
41. A.M. Jubb, T.Q. Pham, A.M. Hanby, G.D. Frantz, F.V. Peale, and T.D. Wu Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours J Clin Pathol 57 2004 504 512
42. E.Y. Soh, S.A. Sobhi, M.G. Wong, Y.G. Meng, A.E. Siperstein, and O.H. Clark Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines Surgery 120 1996 944 947
43. J.L. Shifren, S. Mesiano, R.N. Taylor, N. Ferrara, and R.B. Jaffe Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells J Clin Endocrinol Metab 83 1998 1342 1347
44. G. Gasparini, M. Toi, M. Gion, P. Verderio, R. Dittadi, and M. Hanatani Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma J Natl Cancer Inst 89 1997 139 147
45. M.T. Canning, L.M. Postovit, S.H. Clarke, and C.H. Graham Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells Exp Cell Res 267 2001 88 94
46. S. Kondo, S. Kubota, T. Shimo, T. Nishida, G. Yosimichi, and T. Eguchi Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases Carcinogenesis 23 2002 769 776
47. D.E. Swinson, J.L. Jones, G. Cox, D. Richardson, A.L. Harris, and K.J. O'Byrne Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways Int J Cancer 111 2004 43 50
48. P. Ottino, J. Finley, E. Rojo, A. Ottlecz, G.N. Lambrou, and H.E. Bazan Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity Mol Vis 10 2004 341 350
49. R. Martinez-Zaguilan, E.A. Seftor, R.E. Seftor, Y.W. Chu, R.J. Gillies, and M.J. Hendrix Acidic pH enhances the invasive behavior of human melanoma cells Clin Exp Metastasis 14 1996 176 186
50. W. Niklinska, T. Burzykowski, L. Chyczewski, and J. Niklinski Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis Lung Cancer 34 Suppl. 2 2001 S59 S64
51. T.C. Mineo, V. Ambrogi, A. Baldi, C. Rabitti, P. Bollero, and B. Vincenzi Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer J Clin Pathol 57 2004 591 597
52. C.A. Pinto, P.E. Carvalho, L. Antonangelo, A. Garippo, A.G. Da Silva, and F. Soares Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung Clin Cancer Res 9 2003 3098 3104
53. G. Cox, J.L. Jones, and K.J. O'Byrne Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin Cancer Res 6 2000 2349 2355
54. B.C. Patterson, and Q.A. Sang Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9) J Biol Chem 272 1997 28823 28825
55. L.A. Cornelius, L.C. Nehring, E. Harding, M. Bolanowski, H.G. Welgus, and D.K. Kobayashi Matrix metalloproteinases generate angiostatin: effects on neovascularization J Immunol 161 1998 6845 6852
56. A. Pozzi, W.F. LeVine, and H.A. Gardner Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis Oncogene 21 2002 272 281